North America Microbiology CRO Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
No. of Pages: 133 | Report Code: BMIRE00032141 | Category: Life Sciences
No. of Pages: 133 | Report Code: BMIRE00032141 | Category: Life Sciences
The North America microbiology CRO services market size is expected to reach US$ 4,952.88 million by 2031 from US$ 2,488.24 million in 2023. The market is estimated to record a CAGR of 9.0% from 2023 to 2031.
The North America microbiology Contract Research Organization (CRO) services market is growing steadily, driven by advances in biotechnology, pharmaceutical research, and the increasing demand for outsourcing specialized laboratory functions. Microbiology CROs provide critical services such as antimicrobial efficacy testing, sterility testing, environmental monitoring, and microbiome analysis to support drug development, medical device testing, and biopharmaceutical production. The region’s strong regulatory framework, presence of leading pharmaceutical companies, and emphasis on innovation in life sciences research foster a favorable environment for CRO expansion. Additionally, the rising focus on biologics and vaccines, coupled with the growing prevalence of infectious diseases, has heightened the need for reliable microbiological testing and validation services. Strategic collaborations between pharmaceutical companies and CROs are enhancing research efficiency, accelerating time-to-market, and ensuring compliance with stringent quality standards set by regulatory authorities like the FDA and Health Canada, reinforcing the region’s leadership in outsourced microbiology research.
Key segments that contributed to the derivation of the North America microbiology CRO services market analysis are application, service type, microorganisms, and end user.
Microbial testing service provider CROs have formed numerous partnerships with other stakeholders to expand their service offerings in microbial testing. The partnership activity increased notably in 2022 and 2023, with a focus on acquisitions, manufacturing agreements, and product development, driven by the growing demand for biopharmaceuticals. In August 2023, Frontage Laboratories, Inc. and its subsidiary, Frontage Canada, Inc., acquired Nucro-Technics Inc. and its affiliate, Nucro-Technics Holdings, Inc., a pharmaceutical contract research organization offering various services. Similarly, in October 2022, NAMSA, a leading MedTech CRO, acquired Perfectus Biomed Group, a UK-based laboratory specializing in customized microbiological services. This acquisition expanded NAMSA's presence in the UK and other regions, allowing it to serve clients in over 20 locations spanning the Americas, Asia, and Europe. Therefore, the rise in partnerships and collaborations with the service providers to foster progress and innovation is expected to bring new trends in the microbiology CRO market in the coming years.
Based on country, the North America microbiology CRO services market comprises the US, Canada, and Mexico. The US held the largest share in 2023.
The US is the largest microbiology CRO market in the world and is estimated to dominate the global market during the forecast period. The microbiology CRO market growth in the US is driven by the adoption of modern technologies by contract research organizations, the surging number of clinical trials, and increasing investment in research and development by pharmaceutical and biotechnological companies. Also, strategic initiatives by market players play a significant role in supporting the microbiology CRO market growth. For instance, in February 2024, ICON plc acquired Clinical Research Management, Inc. (ClinicalRM). ClinicalRM offers comprehensive research solutions to various US government agencies. They have extensive expertise in basic and applied research, infectious diseases, vaccine development, testing, and responding to bio-threats. They have collaborated with both government and commercial customers to address the threat of global viral epidemics.
During the forecast period, the microbiology CRO market in the US is anticipated to grow during the forecast period owing to the expansion of services in microbial testing by CROs. For instance, in April 2021, Microbiologics expanded its virology services to support drug and vaccine researchers and developers. The company is investing in an additional 650-square-foot biosafety Level 3 (BSL-3) facility located in its global headquarters in St. Cloud, MN. This expansion follows the completion of its first BSL-3 lab at the company's San Diego, CA facility in August 2020. The new facility will allow for increased capabilities and capacity to provide anti-infective testing, assay development, and biomaterial production services for highly infectious pathogens, including COVID-19 infection and other emerging diseases.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 2,488.24 Million |
| Market Size by 2031 | US$ 4,952.88 Million |
| CAGR (2023 - 2031) | 9.0% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Application
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
Some of the key players operating in the market include Microbiologics; Melbec Microbiology; Emery Pharma; TheraIndx Lifesciences Pvt. Ltd.; AVERIN BIOTECH; Statens Serum Institut; ImQuest BioSciences; PACIFIC BIOLABS; Innovotech Inc.; and BluTest Laboratories Ltd, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
The North America Microbiology CRO Services Market is valued at US$ 2,488.24 Million in 2023, it is projected to reach US$ 4,952.88 Million by 2031.
As per our report North America Microbiology CRO Services Market, the market size is valued at US$ 2,488.24 Million in 2023, projecting it to reach US$ 4,952.88 Million by 2031. This translates to a CAGR of approximately 9.0% during the forecast period.
The North America Microbiology CRO Services Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Microbiology CRO Services Market report:
The North America Microbiology CRO Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Microbiology CRO Services Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Microbiology CRO Services Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Microbiology CRO Services Market
